For patients with a complete response to immunotherapy, or even durable partial response, should immunotherapy be continued until progression or recurrence or is there any data for stopping at a certain time point (i.e. two years)?

Answer from: Medical Oncologist at Academic Institution

There are data that discontinuation is safe, particularly after two years of therapy without progression.

Comments

Medical Oncologist at Kaiser Permanente
Would appreciate sharing of citations of data to s...